Mirabegron and solifenacin are effective for the management of the increased urinary frequency induced by psychological stress in female mice
- PMID: 35858980
- PMCID: PMC9300733
- DOI: 10.1038/s41598-022-16487-7
Mirabegron and solifenacin are effective for the management of the increased urinary frequency induced by psychological stress in female mice
Abstract
Evidence to support the effectiveness of β3-adrenoceptor agonist mirabegron and anti-muscarinic solifenacin in the management of bladder dysfunction caused by psychological stress is lacking. This study investigates whether mirabegron or solifenacin reduces the bladder overactivity caused by water avoidance stress (WAS) in mice. Female mice were exposed to WAS for 1 h/day for 10 days and received either placebo, solifenacin or mirabegron in drinking water. Controls were age-matched without stress exposure. Voiding behaviour and functional isolated whole bladder responses during distension and in response to pharmacological agents and electrical field stimulation was investigated. Urinary frequency was significantly increased following stress. Mice treated with mirabegron or solifenacin displayed significantly fewer voiding events compared to the stressed mice, and voiding frequency in drug-treated animals was comparable to unstressed controls. The maximal contractile responses of bladders to carbachol were significantly enhanced by stress and reduced by mirabegron but not solifenacin. The frequency of phasic bladder contractions following stimulation with carbachol was significantly enhanced following stress and remained elevated in the mirabegron treated group. However, treatment with solifenacin significantly reduced the frequency of phasic contractions to unstressed control levels. Solifenacin and mirabegron are beneficial in reducing the overall voiding dysfunction caused by WAS in mice.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Combined treatment with a β3 -adrenergic receptor agonist and a muscarinic receptor antagonist inhibits detrusor overactivity induced by cold stress in spontaneously hypertensive rats.Neurourol Urodyn. 2017 Apr;36(4):1026-1033. doi: 10.1002/nau.23061. Epub 2016 Jul 1. Neurourol Urodyn. 2017. PMID: 27367573
-
Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony).Eur Urol. 2015 Mar;67(3):577-88. doi: 10.1016/j.eururo.2014.02.012. Epub 2014 Feb 19. Eur Urol. 2015. PMID: 24612659 Clinical Trial.
-
Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: A retrospective analysis.J Obstet Gynaecol Res. 2018 Mar;44(3):524-531. doi: 10.1111/jog.13541. Epub 2017 Dec 22. J Obstet Gynaecol Res. 2018. PMID: 29271106
-
Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder.Neurourol Urodyn. 2019 Jan;38(1):22-30. doi: 10.1002/nau.23863. Epub 2018 Oct 23. Neurourol Urodyn. 2019. PMID: 30350884 Review.
-
Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment.Eur Urol. 2019 Dec;76(6):767-779. doi: 10.1016/j.eururo.2019.07.010. Epub 2019 Aug 13. Eur Urol. 2019. PMID: 31416636 Review.
Cited by
-
Changes in Anxiety-Related Behaviors, Voiding Patterns, and Urinary Bladder Contractile Properties in Male Mice Exposed to Water Avoidance Stress for 1 Day and 28 Days.Biology (Basel). 2024 Sep 9;13(9):707. doi: 10.3390/biology13090707. Biology (Basel). 2024. PMID: 39336134 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical